Bank of Nova Scotia’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-90,888
Closed -$3.74M 1027
2023
Q2
$3.74M Buy
+90,888
New +$4.37M 0.01% 415
2023
Q1
Sell
-223,000
Closed -$12.5M 1181
2022
Q4
$12.5M Sell
223,000
-33,300
-13% -$1.69M 0.03% 315
2022
Q3
$10.9M Buy
+256,300
New +$13.1M 0.03% 290
2022
Q2
Sell
-37,567
Closed -$2.41M 1209
2022
Q1
$2.41M Sell
37,567
-3,000
-7% -$198K ﹤0.01% 771
2021
Q4
$2.72M Sell
40,567
-82,901
-67% -$5.61M ﹤0.01% 839
2021
Q3
$8.46M Buy
123,468
+36,239
+42% +$2.56M 0.01% 515
2021
Q2
$5.95M Sell
87,229
-9,338
-10% -$660K 0.01% 554
2021
Q1
$6.67M Buy
+96,567
New +$6.54M 0.01% 507
2020
Q4
Sell
-96,600
Closed -$4.56M 1019
2020
Q3
$4.56M Buy
96,600
+46,604
+93% +$2.22M 0.01% 482
2020
Q2
$2.35M Buy
+49,996
New +$2.46M 0.01% 544
2017
Q1
Sell
-65,800
Closed -$2.82M 902
2016
Q4
$2.82M Sell
65,800
-5,600
-8% -$228K 0.01% 337
2016
Q3
$2.95M Buy
+71,400
New +$2.99M 0.02% 286

Other funds holding IART

Bank of Nova Scotia's IART Position: Q3 2023 in Review

Bank of Nova Scotia sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 90,888 shares — an estimated $3.74M sold.

Bank of Nova Scotia first reported a position in IART in Q3 2016 and held it in 12 quarters. The position peaked at $12.5M in Q4 2022. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Bank of Nova Scotia reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Bank of Nova Scotia sold 90,888 Integra LifeSciences shares in Q3 2023, an estimated $3.74M.
  • Bank of Nova Scotia first reported a position in Integra LifeSciences in Q3 2016 and held it in 12 quarters.
  • Bank of Nova Scotia's Integra LifeSciences position peaked at $12.5M in Q4 2022.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Bank of Nova Scotia's 13F filing for Q3 2023, filed 14 Nov 2023.